Search our science

Search our scientific publications and resources
on rare bleeding disorders

Molecule
Study Phase
Content Type


Scientific resources from Novo Nordisk

Novo Nordisk supports sharing of the scientific research on our molecules. The search results below include peer-reviewed articles that are authored by Novo Nordisk employees or are funded by Novo Nordisk, as well as congress abstracts, posters and presentations, and also related educational resources.

 

Search Results

We found 359 resources matching your search criteria

Primary manuscript
Hernandez G, Baumann K, Knight S, Purrington H, Gilgannon M, Karelus M, Newman J, Tobase P, Mathew S Cooper DL. Ranges and Drivers of Risk Associated With Sports and Recreational Activities in People With Hemophilia: Results of the Activity-Intensity-Risk (AIR) Consensus Survey of US Physical Therapists. Haemophilia. 2018;24(S7):5-26.
Secondary manuscript
Oldenburg J, Carcao M, Lentz SR, Mahlangu J, Mancuso ME, Matshushita T, Negrier C, Clausen WHO, Ehrenforth S, Young G. Once‐weekly prophylaxis with 40 IU/kg nonacog beta pegol (N9‐GP) achieves trough levels of >15% in patients with haemophilia B: Pooled data from the paradigm trials. Haemophilia. 2018.

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com